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Abstract
This study was designed to determine whether acute fructose or sucrose administration at different levels (0.05 g/kg, 0.1 g/kg or 0.4 g/kg body
weight) might affect oral glucose tolerance test (OGTT) in normal and type 2 diabetic rats. In OGTT, there were no significant differences in
glucose responses between acute fructose- and sucrose-administered groups. However, in normal rats, the AUCs of the blood glucose response for
the fructose-administered groups tended to be lower than those of the control and sucrose-administered groups. The AUCs of the lower levels fructose-
or sucrose-administered groups tended to be smaller than those of higher levels fructose- or sucrose-administered groups. In type 2 diabetic rats, 
only the AUC of the lowest level of fructose-administered (0.05 g/kg body weight) group was slightly smaller than that of the control group. The
AUCs of fructose-administered groups tended to be smaller than those of the sucrose-administered groups, and the AUCs of lower levels fructose-administered
groups tended to be smaller than those fed higher levels of fructose. We concluded from this experiment that fructose has tendency to be more
effective in blood glucose regulation than sucrose, and moreover, that smaller amount of fructose is preferred to larger amount. Specifically, our 
experiments indicated that the fructose level of 0.05 g/kg body weight as dietary supplement was the most effective amount for blood glucose
regulation from the pool of 0.05 g/kg, 0.1 g/kg and 0.4 g/kg body weights. Therefore, our results suggest the use of fructose as the substitute 
sweetener for sucrose, which may be beneficial for blood glucose regulation. 
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Introduction10)
The dietary habit of Koreans has changed progressively to one 
that resembles that of people in the Western world (The Korean 
Nutrition Society, 2006) and this has caused an increase in the 
consumption of sucrose. According to the food balance sheet 
provided by the “Korean Rural Economic Institute”
  (2004), the 
average amount of sucrose supplied for each Korean adult was 
4.8 g per day in 1962 and has increased to 57 g per day in 
2004. Although it is still relatively small compared with that 
of the USA, the production and consumption are still increasing 
(The Korean Nutrition Society, 2006). Type 2 diabetes is 
increasing at epidemic rates in the USA (Mokdad et al., 1999; 
Mokdad et al., 2000; Mokdad et al., 2001) and in the developing 
countries including China (Pan et al., 1997) and India 
(Ramachandran et al., 1997). From 1935 to 1996, the prevalence 
of diagnosed type 2 diabetes climbed nearly 765% (Centers for 
Disease Control and Prevention NCfHS, Division of Health 
Interview Statistics, 1997). The global figures are predicted to 
rise 46% from 150 million cases in 2000 to 221 million in 2010 
(Zimmet et al., 2001). The incidence of type 2 diabetes is also 
at an epidemic level in Korea and is increasing. For example, 
the incidence of diabetes for those aged 30 years or older has 
increased from 6.6% in 1998 to 8.1% in 2005 (Ministry of Health 
and Welfare, 1999; Ministry of Health and Welfare, 2006). 
Epidemiological studies have identified a significant positive 
correlation between dietary sucrose intake and the incidence of 
diabetes (Basciano et al., 2005). We suspect that this steady 
increase in sucrose consumption in Korea will contribute to the 
increase of diabetes (Basciano et al., 2005), so there is an urgent 
need for the selection and application of appropriate substitute 
sweeteners. 
Fructose is believed to be more slowly absorbed from the 
gastrointestinal tract than glucose. When disaccharides such as 
sucrose or maltose enter the intestine, they are cleaved by 
disaccharidases. A sodium-glucose cotransporter absorbs glucose 
that is formed from the cleavage of sucrose. In contrast, fructose 
has no active absorption mechanism in the intestinal mucosa but 
is slowly and incompletely absorbed by facilitated diffusion 
(Bray  et al., 2004; Uusitupa, 1994). Because of this slow 
absorption, the blood glucose-increasing effect of fructose is 
lower than after ingestion of most other carbohydrate sources 
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(Bantle et al., 1983; Cannon et al., 1986; Crapo & Kolterman, 
1984; Henry et al., 1991; Jeckins et al., 1981; Swan et al., 1966). 
After absorption, glucose and fructose enter the portal circulation 
and are transported to the liver, where fructose can be taken up 
and converted to glucose, or pass into the general circulation 
(Bray et al., 2004). Fructose is metabolized mainly by the liver 
and to a lesser extent by the kidney and intestinal mucosa 
(Ludwig  et al., 1999; Truswell, 1992). Fructose transepithelial 
transport in intestine is initiated at the apical side by GLUT 5 
and GLUT 2, and is thought to be released through the basolateral 
membrane by GLUT 2 (Kellett & Brot-Laroche, 2005). In the 
metabolism of fructose, the first reaction is catalyzed by 
fructokinase, an enzyme that is not dependent on insulin. Fructose 
does not stimulate insulin secretion from pancreatic β cells. The 
lack of stimulation by fructose is likely because of the low 
concentrations of the fructose transporter GLUT5 in β  cells 
(Basciano et al., 2005; Bray et al., 2004; Curry, 1983; Mayer, 
1993; Sato et al., 1996; Uusitupa, 1994). In contrast to sucrose 
and glucose, some nutritionists regard fructose as a relatively 
safe form of sugar. Because it does not require insulin for uptake 
into cells, moderate fructose intake does not affect blood glucose 
levels adversely, at least in the short term (Bantle et al., 1986). 
Glycemic index (GI) is a system of classifying carbohydrate- 
containing foods according to how fast they are digested and 
absorbed during the postprandial period. The GI has a value of 
100 for glucose and baked potato, 19 for fructose and 68 for 
sucrose (Truswell, 1992).
  A related concept, glycemic load (GL), 
also takes into consideration the amount of carbohydrates in 
portion of food (Ciok & Dolna, 2006). Glycemic Index (GI) and 
Glycemic Load (GL) play a pivotal role in carbohydrate 
classification and for food choice by diabetic patients. Postprandial 
glycemic response and insulinemia are strongly related to the 
values of GI and GL (Pankowska et al., 2006). Several recent 
studies have suggested that consuming low GI and GL diet may 
be associated with a lower risk for type 2 diabetes (Salmeron 
et al., 1997a; 1997b; 1997c). In addition, fructose is sweeter than 
sucrose. In sweetness comparative studies, when sucrose is set 
at a scale of 100, fructose is 173 and glucose is 74 (Schauberger, 
1977). For these reasons, it has been proposed as a useful energy 
source and a substitute for sucrose in the diet for patients with 
diabetes (Bantle, 1989; Koivisto, 1978; Nutrition Subcommittee of 
the British Diabetic Association’s Professional Advisory Committee, 
1990; Olefsky & Crapo, 1980). However, diets specifically high 
in fructose have been shown to contribute to metabolic disturbances 
in animal models resulting in weight gain, hyperlipidemia and 
hypertension (Hwang et al., 1987; Kasim-Karakas et al., 1996).
Some studies examining the effects of fructose consumption 
on blood glucose regulation have shown conflicting results 
(Jurgens et al., 2005). The optimal dose of fructose compared 
with sucrose has not been well evaluated. The metabolic 
consequence of fructose, compared with sucrose, needs to be 
examined in experimental animals and human with normal or 
type 2 diabetes (Olefsky & Crapo, 1980). Therefore, this study 
was designed to determine whether the supplement of different 
levels of fructose or sucrose might affect blood glucose regulation 
in Sprague-Dawley (SD) and Goto-Kakizaki (GK) rats with type 
2 diabetes, respectively. The goal was to determine the effect 
of fructose, compared with sucrose, on glucose tolerance, as 
dietary supplements.
Materials and Methods
Animals and Diets
Seventy male SD rats of nine-month old [Slc (SD), Outbred, 
Charles River Origin, Japan SLC, Inc] were placed in individual 
stainless steel wire-mesh cages in a room with 12:12 h light-dark 
cycle, temperature of 22-24℃ and a relative humidity of 45 ±
5%. The rats were fed with a normal diet for the first seven 
days of adaptation. The diet was formulated according to the 
nutrient content of the 93M diet of the American Institute of 
Nutrition (AIN) (Portha et al., 1991). Cornstarch (Dyets Inc., 
USA) was included as a source of carbohydrate, soybean oil (CJ 
Co., Korea) was included as a source of lipid and casein (Dyets 
Inc., USA) was included as a source of protein. Mineral and 
vitamin mixtures, prepared in accordance with the 1993 
recommendation of the AIN, were purchased from Dyets, Inc., 
USA. SD rats weighed 632 ± 15 g at the end of the adaptation 
period. They were then stratified according to body weight and 
allocated randomly into seven groups for the experimental period.
Seventy male GK rats of six-week old [GK/Slc, Inbred, Tohoku 
University School of Medicine, Japan SLC, Inc] were placed in 
individual stainless steel wire-mesh cages in a room with 12:12 
hr light-dark cycle, temperature of 22-24℃ and relative humidity 
of 45 ± 5%. The rats were fed with a normal diet for the first 
seven days of the adaptation period. The diets of GK rats were 
formulated according to the nutrient content of the 93G diet of 
the AIN (Portha et al., 1991). The GK rat is a spontaneous diabetic 
animal model of non-insulin-dependent diabetes mellitus, which 
is characterized by progressive loss of β-cells in the pancreatic 
islets with fibrosis. This model was produced by repeated 
selective breeding of rats with glucose intolerance starting from 
a nondiabetic Wistar rat colony. The characteristics of the GK 
rat include mild hyperglycemia at fasting, impaired glucose 
tolerance on glucose load and impaired secretion of insulin in 
response to glucose in vivo (Hasegawa et al., 2001; Koyama 
et al., 1998; Ostenson et al., 1993; Ostenson, 1996). The GK 
rats weighed 132 ± 5 g at the end of the adaptation period. The 
rats were then stratified according to body weight and blocked 
randomly into seven groups for the experimental period. 
This study was conducted at the nutrition laboratory of Ewha 
Womans University in compliance with the Guide for the Care 
and Use of Laboratory Animals (Ostenson et al., 1993). The rats 
were allowed free access to the experimental diets and deionized 
water during the experimental period. Body weights were 254 Effect of fructose or sucrose on oral glucose tolerance test in rats
Table 1. Experimental design of the Study 
Group
1)
Adaptation
period
(7 days)
Load solutions used in oral glucose tolerance 
tests (all in g/kg body weight)
C
Normal diet
Glucose 1 
0.05S Glucose 1 + Sucrose 0.05
0.1S Glucose 1 + Sucrose 0.1
0.4S Glucose 1 + Sucrose 0.4
0.05F Glucose 1 + Fructose 0.05
0.1F Glucose 1 + Fructose 0.1 
0.4F Glucose 1 + Fructose 0.4 
1) C :  C o n t r o l g r o u p ;  O G T T  ( g l u c o s e  1  g / k g  b o d y  w e ig h t )
0.05S:  Sucrose  administration  group;  OGTT+S  (0.05  g/kg  body  weight)
0.1S:  Sucrose  administration  group;  OGTT+S  (0.1  g/kg  body  weight)
0.4S:  Sucrose  administration  group;  OGTT+S  (0.4  g/kg  body  weight)
0.05F:  Fructose  administration  group;  OGTT+F  (0.05  g/kg  body  weight)
0.1F:  Fructose  administration  group;  OGTT+F  (0.1  g/kg  body  weight)
0.4F:  Fructose  administration  group;  OGTT+F  (0.4  g/kg  body  weight)
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Fig. 1. The changes in blood glucose concentration during an oral glucose 
tolerance test in SD rats 
recorded once a week. For determination of food intake, the 
amount of food offered was weighed and the weights of any 
orts were recorded three times per week.
Oral glucose tolerance test 
The design of experiments is shown in Table 1. In the 
experiment, different levels of fructose (Crystalline fructose 
99.5%, Kato Kaguku Co., Japan) or sucrose (Daesang Co, Korea) 
were administered to normal SD and type 2 diabetic GK rats 
as supplements to test their effects on blood glucose regulation 
using the OGGT.
After the rats had fasted for 12 h, a 50% glucose solution 
(1 g/kg of body weight) with the supplement of fructose or 
sucrose at different levels (0.05 g/kg, 0.1 g/kg or 0.4 g/kg body 
weight) was orally administered, and blood was taken from the 
tail vein at 0 (before the solution load), 30, 60, 90 and 120 min 
afterward (The Korean Society of Food Science and Nutrition, 
2000). Blood glucose concentrations were determined immediately 
using an Accu-chek (Roche Diagnostics, Germany). According 
to studies on the OGTT in which glucose solution is added with 
fructose, the typical amount of fructose added is about 10% (w/w) 
of the glucose solution. Moreover, adding a smaller proportion 
of fructose was shown to be more effective in observing the 
regulating effect on blood glucose than adding a larger amount 
(Moore  et al., 2000). For these reasons, we set the fructose 
amount to be added to the glucose solution to 5% and 10% (w/w) 
of the glucose solution in this study. These amounts correspond 
to 0.05 g and 0.1 g per kg of body weight, respectively, for the 
glucose solution at 1 g per kg of body weight. For completeness, 
we also tested the case in which the added fructose amount was 
greater than 10% (w/w) of the glucose solution. In this case, 
fructose was 0.4 g per kg of body weight derived from the intake 
of added sugar, which is the equivalent of 19.1 g per day for 
a normal 60 kg adult Korean (Dietary Reference Intakes for 
Koreans, 2005). The increment in blood glucose after the glucose 
load was expressed in terms of AUC from the time when the 
fasting blood was drawn until 120 min postload blood sampling. 
AUC was calculated by WinNolin program (version 1.1, Pharsight 
Co., USA). 
Statistical Analysis
All statistical analyses were performed by the SAS program 
package version 9.1. All results were expressed as the mean ±
standard error (SE). The data were analyzed by one-way analysis 
of variance (ANOVA) and differences between experimental 
groups were evaluated using Duncan’s multiple range tests at 
the p<0.05 significance level. 
Results
Oral glucose tolerance in normal rats
Daily food intake and body weight change per week in SD 
rats were not significantly different among any groups. In this 
study, the range of daily food intake and body weight change per 
week were 29.85~33.36 g/day and 3.79~4.55 g/day, respectively. 
The OGTT results for SD rats are shown in Fig. 1. There was 
no significant difference in the glucose response between the 
acute fructose and sucrose administered groups. At 30 min and 
60 min after solution ingestion, although there were no significant 
differences between treatments, blood glucose concentrations of 
rats administered the 0.1F or 0.4F diets tended to be lower than 
those of the rats administered the 0.1S or 0.4S levels, respectively. 
At 90 min and 120 min after solution ingestion, the blood glucose 
concentrations of the fructose-administered groups tended to be 
lower than those of the sucrose-administered groups at matching 
concentration. Supplement of fructose to the glucose load tended 
to reduce the glycemic response to the OGTT. 
The AUC data of the glucose response in SD rats is shown 
in Fig. 2. There was no significant difference in the AUC of 
the glucose response between acute fructose- and sucrose- Sanghee Kwon et al. 255
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Fig. 2. The areas under the curve of the glucose response in SD rats 
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Fig. 3. The changes of blood glucose concentration during oral glucose 
tolerance test in GK rats 
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Fig. 4. The areas under the curve of the glucose response in GK rats 
administered groups, whereas the AUCs of fructose-administered 
groups tended to be smaller than those of control or sucrose- 
administered groups at matching concentration. The AUCs of 
lower-level fructose- or sucrose-administered groups tended to 
be smaller than those of groups administered higher levels of 
fructose or sucrose at matching concentration. The AUCs of the 
0.05F, 0.1F, 0.4F and 0.05S groups tended to be smaller than 
that of the control group, and the AUC of the 0.05F group was 
the smallest. The AUCs of fructose-administered groups tended 
to be smaller than those of the sucrose-administered groups. The 
AUC of the glucose response, calculated as the change from basal 
values in each group, was about 0.01% smaller with the 0.05F 
diet than with the 0.05S diet. It was 7% smaller with the 0.1F 
diet than with the 0.1S diet and 10% smaller with the 0.4F diet 
than with the 0.4S diet. The AUC of the glucose response was 
about 10% smaller with the 0.05F diet than with the control diet. 
The supplement of fructose to the glucose load tended to improve 
glucose tolerance in these SD rats.
Oral glucose tolerance in diabetic rats
Daily food intake and body weight change per week in GK 
rats were not significantly different among any groups. In this 
study, the range of daily food intake and body weight change 
per week was 14.67~15.59 g/day and 4.59~5.19 g/day, respectively. 
The OGTT data for GK rats are shown in Fig. 3. There was 
no significant difference in the glucose response between the 
acute fructose- and sucrose-administered groups. At 30 min after 
solution ingestion, blood glucose concentrations of the sucrose- 
administered groups were higher than those of the fructose- 
administered groups. At 60, 90 and 120 min after solution ingestion, 
blood glucose concentrations of the fructose-administered groups 
tended to be lower than those of sucrose-administered groups 
at matching concentration, except for the 0.1F and 0.1S groups 
at 60 min. At 30 and 60 min, the blood glucose concentrations 
of the control group tended to be lower than those of the 
experimental groups. At 90 and 120 min, the blood glucose 
concentration of the 0.05F group tended to be lower than those 
of the other groups. Supplement of fructose to the glucose load, 
compared with supplement of sucrose to the glucose load, tended 
to reduce the glycemic response to the OGTT. In contrast to 
data for normal animals, diabetic rats should be higher blood 
glucose level during the first 120 min after 12 hr of fasting than 
normal rats. Furthermore, while the blood glucose level of normal 
rats was peaked at around after 30 min from 12 hr of fasting, 
that of diabetic rats was peaked after 30 min to 60 min from 
12 hr of fasting.
The AUCs of the glucose response in GK rats are shown in 
Fig. 4. There were no significant differences between the acute 
fructose- and sucrose-administered groups, whereas the AUCs 
of fructose-administered groups tended to be smaller than those 
of the control or sucrose-administered groups at matching 
concentration. The AUCs of higher-level fructose- or sucrose- 
administered groups tended to be larger than those of rats 
administered lower-level fructose or sucrose diets, except for the 
0.05S and 0.1S groups. Only the AUC of the 0.05F administered 
group tended to be smaller than that of the control group. The 
AUC was the smallest in the 0.05F group, followed by the 256 Effect of fructose or sucrose on oral glucose tolerance test in rats
control, 0.1F, 0.4F and sucrose-administered groups. The AUC 
of glucose response, calculated as the change from basal values 
in each group, was approximately 7% smaller with the 0.05F 
diet than with the 0.05S diet, 6% smaller with the 0.1F diet than 
with the 0.1S diet, and 6% smaller with the 0.4F diet than with 
the 0.4S diet. The AUC of the glucose response was about 0.7% 
smaller with the 0.05F diet than with the control diet. 
Consequently, the AUCs of fructose-administered groups tended 
to be smaller than those in the sucrose-administered groups, and 
the AUCs of the lowest-level fructose-administered groups were 
the smallest. In conclusion, the supplement of a small amount 
of fructose to a glucose load, compared with supplement of a 
small amount of sucrose to a glucose load, tended to improve 
glucose tolerance in GK rats with type 2 diabetes.
Discussion
In this study, different levels of fructose or sucrose were 
administered to normal SD and type 2 diabetic GK rats as 
supplements to test their effects on blood glucose regulation, 
using the OGTT. The present study implies that the addition of 
fructose seems more attributive to blood glucose regulation 
regardless of the added amount in comparison with sucrose 
administration. Moreover, in our present study where we 
conducted adding three different amounts of fructose, the results 
imply that smaller amount of added fructose induces more 
effective blood glucose regulation while not significantly. Had 
fructose been added more consistently over a period of time, 
as opposed to just once as done in this study, a clearer effect 
of fructose administration in blood glucose regulation might have 
been observed in agreement with the known results in the 
literature. Furthermore, we also expect to observe a more 
definitive result had we used mid-aged rats that have difficulty 
in blood glucose regulation as opposed to young rats as done 
in this study. In the future, more extensive experiments regarding 
the blood glucose regulation need be explored. The fact that 
supplemental fructose contributing to blood glucose regulation 
can be explained from metabolic adaptation-in other words, the 
ability to suppress endogenous glucose production during 
hyperglycemia and increased net hepatic glucose uptake and 
metabolism in normal subjects. There are various studies on the 
effect of supplement of fructose or sucrose to blood glucose in 
OGTTs in which fructose or sucrose was added to the glucose 
load in normal subjects. Moore et al. (2000) examined the effect 
of fructose on glucose tolerance in 11 normal human volunteers. 
Each volunteer underwent an OGTT that consisted of 75 g of 
glucose with or without 7.5 g of fructose on two separate 
experiments at least one week apart. The OGTT with fructose 
in comparison with that without fructose showed significantly 
smaller AUC of the change in plasma glucose (p<0.05). Low- 
dose fructose improves the glycemic response to an oral glucose 
load in normal adults without significantly enhancing the insulin 
or triglyceride responses. The increase in the arterial blood 
glucose concentration during fructose infusion was only half as 
great as it was in the absence of fructose (Shiota et al., 2002). 
In that study, the increased glycolytic flux associated with the 
inclusion of fructose was probably secondary to an increase in 
the intracellular glucose 6-phosphate content. This in general is 
secondary to the activation of glucokinase, perhaps with an 
associated increase in the activity of phosphofructokinase (Shiota 
et al., 2002). A small proportion of ingested fructose generally 
improves glycemic control because it increases net hepatic 
glucose uptake via enhanced translocation of glucokinase, increased 
hepatic glycogen synthesis and hepatic glycolysis (Petersen et 
al., 2001). Increased amount of added fructose resulted in a 
reduced blood glucose regulating effect. The fact that an increased 
supplement of fructose translates to extra calories, which 
transform to glucose and eventually to a higher blood glucose 
level, can account for this (Faeh et al., 2005). If fructose intake 
is very high, or if it leads to excessive energy consumption, it 
can have an adverse effect on glucose regulation (Levi & Werman, 
1998).
There have been studies on the effects of supplement with 
fructose or sucrose on the blood glucose level during OGTTs 
in diabetic subjects. In the present study, we observed that the 
AUC of only the 0.05F group tended to be smaller than that 
of the control group. The blood glucose regulations of sucrose- 
administered groups tended to be poorer than those of the 
fructose-administered groups. Unlike the normal animals, higher 
fructose supplement in the diabetic rats had adverse effects on 
blood glucose regulation compared with control group. For 
diabetic animals, insulin secretion becomes uncontrollable after 
an intake of high amount of sugar, and the ability to suppress 
endogenous glucose production during hyperglycemia becomes 
impaired. These experimental results suggest that higher doses 
of fructose increase the blood glucose level and that only small 
doses of fructose will have beneficial effects on blood glucose 
regulation in diabetic subjects. Moore et al. (2001) studied five 
adults with type 2 diabetes who underwent an OGTT that 
consisted of 75 g of glucose with or without 7.5 g of fructose 
on two separate experiments that took place at least one week 
apart. The subjects with type 2 diabetes demonstrated a 14% 
reduction in the AUC of the glucose response to an OGTT when 
a small dose of fructose was added to the glucose load. The 
improvement in glucose tolerance with fructose ingestion in this 
study did not occur at the expense of increased insulin secretion. 
Wolf et al. (2002) evaluated the effects of supplemental fructose 
on postprandial glycemia in an animal model. After overnight 
food deprivation, Zucker fatty (fa/fa) rats were given a meal 
glucose tolerance test. At a dose of 0.16 g/kg body weight, 
fructose reduced the AUC by 34% when supplemented to a 
glucose challenge (1 g/kg). In a dose-response study (0.1, 0.2 
and 0.5 g/kg body weight), supplemental fructose reduced the 
peak rise in plasma glucose (p<0.01). A low dose of fructose 
(0.075 g/kg body) reduced (p<0.05) the AUC by 18%. These Sanghee Kwon et al. 257
findings have great clinical potential for the prevention of 
postprandial hyperglycemia in people with diabetes. Atkinson et 
al (2000) reported that supplemental fructose (1, 2 and 4 g/kg 
body weight) reduced (p<0.05) the early (10 min) postprandial 
plasma glucose concentrations after a glucose challenge. However, 
the incremental AUC for plasma glucose was unaffected.
The mechanism by which a small dose of fructose can decrease 
the blood glucose level in normal rats may be explained as 
follows. When glucose and fructose are supplemented together, 
they compete for GLUT2 which exists in the apical surface so 
that fructose is induced to suppress the absorption of glucose. 
Recently, Kellett and Brot-Laroche (2005) have discovered a new 
pathway of sugar absorption, the apical GLUT2 pathway. GLUT2 
is an attractive candidate as the dominant sugar transporter 
because it is a high-capacity transporter, has a much higher Km 
for glucose and fructose, and transports both substrates (Kellet 
& Brot-Laroche, 2005; Kwon et al., 2007). In the classical model, 
GLUT2 has an exclusively basolateral location. But, more recent 
localization data showed that GLUT2 localizes to the apical 
surface. Binding sites on GLUT2 for fructose and glucose are 
the same (Corpe et al., 1996; Kellett & Helliwell, 2000). Higher 
blood glucose level and less effective blood glucose regulation 
were observed when we performed OGTT to diabetic rats than 
to normal rats. This can be accounted for by the impaired insulin 
secretion which leads to reduced translocation of GLUT4 in 
diabetic rats. The latter is associated with decreased glucose 
transport in type 2 diabetic rats (Watson & Pessin, 2001; Wood 
& Trayhum, 2003). Increased supplement with fructose translates 
to extra calories, which in turn transforms to glucose. Eventually, 
these higher blood glucose levels can account for this reduced 
regulation.
We concluded from this experiment that fructose has tendency 
to be more effective in blood glucose regulation than sucrose, 
and moreover, that smaller amount of fructose is preferred to 
larger amount. Specifically, our experiments indicated that the 
fructose level of 0.05 g/kg body weight as dietary supplement 
was the most effective amount for blood glucose regulation from 
the pool of 0.05 g/kg, 0.1 g/kg and 0.4 g/kg body weights. 
Therefore, our results suggest the use of fructose as the substitute 
sweetener for sucrose, which may be beneficial for blood glucose 
regulation.
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